...
首页> 外文期刊>Arquivos de Gastroenterologia >Transplante de fígado no Brasil: necessidade urgente de um novo sistema de aloca??o para as exce??es no escore MELD.
【24h】

Transplante de fígado no Brasil: necessidade urgente de um novo sistema de aloca??o para as exce??es no escore MELD.

机译:巴西的肝移植:迫切需要一个新的分配系统,以便在融合中兴奋。

获取原文

摘要

The Model for End-stage Liver Disease (MELD) was adoptedfor liver transplant allocation in USA in 2002, and in Brazil in 2006.The rational of this change was to prioritize the sicker patients,promote a better use of grafts, a less mortality in the waiting list,and a better allocation system with more equality and justice. Themodel was adopted worldwide due to its characteristics of beingsimple and a good predictor of mortality for patients with severechronic liver disease. However, there are some diseases in whichthe patients need to be transplanted but their score would neverreach a transplantable number. For this reason, many countriesproposed extra points for patients that do not fit the MELDformula – the “MELD exceptions”. The number of extra pointsand the criteria are not standardized in all countries and they aresomehow subjective(1).One example is the HCC patient. In mostcountries following a restrictive criteria (ex: Milan criteria) patientswith HCC receive extra points in MELD score in order to be transplantedin a time that minimize the chance of losing such criteriaor dying in the waiting list. The problem is the big difference interms of transplantable MELD score between the regionals insidethe country (states), the ABO blood types, the MELD exceptionsthemselves, and also the dynamic changes in the MELD requiredto be transplanted over time.
机译:2002年美国肝脏移植分配和巴西采用了终末期肝病(MELD)的模型。这一变化的理性是优先考虑病人患者,促进更好地利用移植物,较少的死亡率等候名单,以及具有更多平等和正义的更好的分配系统。由于其特点,在全世界采用了Themodel,因为它的特点以及用于肝脏疾病的患者的患者的良好预测因子。然而,存在一些疾病,其中患者需要移植,但它们的分数将永远不会进入可移植的数量。出于这个原因,许多国家为不适合梅尔布林的患者提供了额外的点 - “融合的例外”。额外指点的数量并不在所有国家/地区标准化,它们是一个主观(1)。一个例子是HCC患者。在受限制标准(例如:米兰标准)患者的MOSTCORIESWITH HCC中获得额外的分数,以便进行转移素,这使得在等待名单中失去死亡的这种标准的可能性最小化。问题是区域人思路(州),ABO血液类型,融合出异常的转移融合得分的大区别互联器,以及融合中的动态变化被随时间移植。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号